<<
>>

2.2.2. diffuzionnoj abilities of lungs

Diffuzionnuju ability of lungs (DL) studied research by a delay method

Respirations on WITH on the apparatus "Rcsparamctcr. МК-4". The gas structure and pokazayoteli the acid-basic condition was defined micromethod Astrupa on apparatus Astrupa of type BMg-З by firms "Radiomeeicr" (Denmark).

On purpose opreyodelenija types of disturbances of ventilating ability of lungs (obstruktiv th, restrnktivnyj, admixed), expression and convertibility bronhialyonoj obstructions are used the specifications developed in mezhklinicheyo

skoj laboratories of function of external breath SPbMU it. akad. I.P.PavYolova and GNTSP MZ the Russian Federations corresponding to the international criteria.

<< | >>
Scientific source Yefimova Olga Aleksandrovna. ESTIMATION of EFFICIENCY of TREATMENT GLJUKOKORTIKOSTEROIDNYMI PREPARATIONS of LUNGS SICK of CHRONIC OBSTRUCTIVE ILLNESS. The DISSERTATION on competition of a scientific degree of the candidate of medical sciences. St.-Petersburg - 2007. 2007

Other medical related information 2.2.2. diffuzionnoj abilities of lungs:

  1. 6.2 Results of application of a preparation of system enzymotherapy (Vobenzim) as an agent strengthening action of a causal treatment at children with OSL (croup)
  2. THE CONCLUSION
  3. THE LITERATURE LIST
  4. Free radicals in physiology and a pathology of lungs
  5. 1.2 Clinico-functional characteristic of bronho-pulmonary process at a mucoviscidosis and modern methods of functionaldiagnostics
  6. Chapter 4 of Feature of function of external breath at observable children with a mucoviscidosis (results of own researches)
  7. the MAINTENANCE
  8. INTRODUCTION
  9. 1.4. A role of glucocorticoid hormones at diseases of lungs
  10. 2.1. The clinical characteristic of the surveyed patients
  11. 2.2. Research methods
  12. 2.2.2. diffuzionnoj abilities of lungs
  13. 2.2.3. Microcirculation research in lungs
  14. 3.1.6. Clinical examples.
  15. 3.2.1. Dynamics of laboratory-tool indicators v patients HOBL against therapy by broncholitic preparations (group O
  16. 3.2.2 Dynamics of laboratory-tool indicators at patients HOBL against therapy broncholitic and inhalation gljukokortikostsroidiymi preparations (group 2)
  17. 3.2.3. Dynamics of laboratory-tool indicators at patients HOBL in a combination with BA against therapy broncholitic and inhalation gljukokortnkosteroidnymn preparations (group 3)
  18. 3.2.4. Dynamics laboratory-nistrumentapnyh indicators at patients HOBL in acombination with GZBA against therapy bronholiticheskimn preparations and inhalation gljukokortikosteroidnymi preparations (group 4)
  19. CHAPTER 4. DISCUSSION of the RECEIVED RESULTS
  20. PRACTICAL REFERENCES